Why Ziopharm Oncology Shares Rose 10.5% on Wednesday

Why Ziopharm Oncology Shares Rose 10.5% on Wednesday

Source: 
Motley Fool
snippet: 

Shares of Ziopharm Oncology (NASDAQ:ZIOP) jumped by 10.8% on Wednesday. The clinical-stage biopharmaceutical company is examining non-viral T-cell receptor therapies (TCR-T) to fight cancer. Its shares closed on Tuesday at $0.8553, then opened Wednesday at $0.8770, climbing to a high of $0.95 before falling back a bit in the afternoon, closing at $0.8961 on Wednesday.